OpenAI will not pursue an IPO in 2026, Sam Altman says, citing AI safety concerns and mounting pressure from lawmakers for new rules
OpenAI chief executive Sam Altman confirmed on 12 September 2026 that the company will not go public this year, reversing expectations that had built around a potential 2026 listing. Altman cited AI safety concerns and a growing wave of warnings from researchers and regulators about the pace of AI development, alongside calls from lawmakers for new legislative frameworks. The decision follows a period in which prominent voices inside and outside the AI industry have raised alarms about rapidly advancing technology. Lawmakers in multiple jurisdictions have pressed for new rules governing frontier AI models before any major AI developer reaches public markets. Altman's public statement makes clear the company views a 2026 IPO (initial public offering, meaning the first sale of a company's shares to public investors) as incompatible with the current political and safety environment. The announcement removes what would have been one of the most closely watched capital markets transactions in recent memory. OpenAI had been widely discussed as a candidate for a landmark technology listing, and its absence from the 2026 IPO pipeline materially narrows the slate of high-profile technology offerings available to institutional investors this year. The decision also keeps OpenAI in its current corporate structure, meaning it continues to operate under the scrutiny that has accompanied its ongoing conversion from a non-profit to a for-profit entity, a transition with its own regulatory and governance dimensions.
Why this matters
An OpenAI IPO would have ranked among the largest technology listings in years, so its indefinite postponement is a significant signal for the capital markets pipeline. The stated reason, AI safety, is notable: it suggests that regulatory uncertainty around frontier AI is now a factor capable of delaying even the most anticipated public offerings, not merely a compliance footnote. For London and European capital markets practitioners, the decision reinforces the broader pattern of high-value technology companies remaining private longer, continuing to rely on private capital markets rather than public listings. The political dimension, with lawmakers explicitly calling for new rules before any listing proceeds, introduces a novel form of regulatory overhang into the AI sector's capital markets trajectory.
On the Ground
Capital markets teams advising technology clients will be monitoring how AI-specific regulatory risk is being factored into IPO readiness assessments and investor due diligence processes. The continued private status of OpenAI sustains demand for private placement and secondary market advisory work. A trainee on a technology IPO matter would typically be assisting with prospectus drafting and proofreading, preparing verification notes, and coordinating listing application forms, tasks that remain in preparation even when a listing is deferred.
Interview prep
Question you might get
“How does regulatory uncertainty around a company's core product affect its IPO readiness, and what would lawyers advising OpenAI need to work through before any future listing?”
Sign up free to see the full answer
A model answer you can lift into an interview — how to frame this story for a partner.
Sign up freeSources
My notes
saved